THE WHAT? Johnson & Johnson has reported its results for the first quarter of fiscal 2023. The US manufacturer of baby care products saw sales swell 5 percent to US$23.4 billion, with operational growth of 7.7 percent. Earnings per share dropped 16.8 percent to US$1.93.THE DETAILS In terms of regional performance, US sales inched up 2.7 percent compared to the prior year quarter while International sales rose 7.2 percent.Drilling down by sector, the company's Consumer Health division put in a flat performance, dipping 1.